Long-Term Care

CMS updates unnecessary drugs F-Tag

Contemporary Long-Term Care Weekly, December 27, 2006

On December 18, CMS made more revisions to F-Tag #329, Unnecessary Drugs, requiring increased involvement from consultant pharmacists. These changes require nursing homes to provide detailed documentation on why a resident should or should not be tapered off a medication. Under F-Tag #329, CMS added requirements for physicians to document the clinical rationale of why attempting a dose reduction on a resident would be contraindicated. CMS also deleted the duration information about cholinesterase inhibitors in the medication table under cognitive enhancers. Click here to see all of the changes.

Most Popular

Related Articles